Nanobiotechnology and Nanomedicine Companies
(Links listed alphabetically)
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All
Showing results 76 - 100 of 254
Cytocentrics AG is a biotechnology company applying its ion channel expertise to support the pharmaceutical industry in the drug discovery process.
CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening. The company develops, manufactures, and distributes products that make cellular analysis robust and reliable by drastically decreasing cell variability.
One of the company's delivery systems in the most advanced stages of clinical development is a novel drug delivery system for Paclitaxel. Because of the better safety and pharmacokinetic profile, the polymeric nanoparticle delivery system is seen as a potential super generic.
Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates.
Applies nanotechnology to the design and manufacture of pumps, coatings and micro-needle arrays.
Deerac Fluidics is a global leader in microlitre and nanolitre liquid handling systems for the Life Sciences industry.
Delpor develops the next generation Drug Delivery Systems that improve the clinical and commercial value of drugs and biopharmaceuticals. The company also has developed a microfabricated nanopore device for the sustained release of therapeutic agents.
The company's NLP technology produces a generation of particles which retains the strength of the Dermazone Solutions' (SDMC) technologies, but includes the ability to produce particles of 60 nanometers to 150 nanometers which are optically clear. The use of this generation of lipid-based particle delivery system provides the ability to control the size of the final particle by controlling the number of NLPs used to assemble the finished particle. This system maintains very high loading capacity of passenger molecules and uses only safe, all natural ingredients to form both the NLPs and the final delivery system.
DiagnoCure has specialized in the development, production and commercialization of molecular diagnostics for the detection and management of cancer
Digilab offers a wide range of sample preparation and liquid handling tool, and a imaging and spectroscopy products for sample identification for the Life Science, Analytical Chemistry and Diagnostic markets.
A specialized biomedical instrument designer, manufacturer, sales and consulting company.
Dune Sciences is an emerging technology company specializing in products and services that will facilitate the development and commercialization of nano-enabled products. The company employs several patented and patent-pending technologies to engineer interfaces for the integration of new materials and devices in medicine, bionanotechnology, energy technologies, and nanoscience.
The company's proprietary NanoCrystal® technology can enable formulation and improve compound activity and final product characteristics for poorly water-soluble compounds.
Endomagnetics was founded to solve healthcare challenges through the application of advanced magnetic sensing technology.
The company's mission is to develop and license R&D projects in Nanotechnology applied to Life Sciences. Endor is also developing pioneer in-house projects in novel Nanomaterials.
Serving as a contract research organization, Endotherm Life Science Molecules is a provider of medicinally relevant compounds for the discovery and development of novel small molecule drugs. The product range includes focused compound libraries, building blocks and reagents for the development of biochemical assays (fluorescent and bioluminescent dyes).
EnGeneIC aims to revolutionize the treatment of cancer by targeted delivery of drugs or siRNAs using the same versatile nano-sized delivery vehicle to address the complexities found in cancer cells.
Ensemble Therapeutics is utilizing DNA Programmed Chemistry (DPC), an innovative method for creating new chemical bonds. Ensemble integrates DPC into a nanoscale selection system that combines chemistry, biology and informatics to discover novel compounds.
The company is focused on the use of fullerene carbon nanotubes for novel therapeutic applications specifically in the area of cancer treatment. The company's extensive carbon nanotube-related, worldwide intellectual property portfolio includes discoveries by the late Nobel Prize winner Dr Rick Smalley. The use of fullerene carbon nanotubes has the goal of solving two important problems for many cancer therapeutics, that of delivering large active agents into the desired location and of protecting normal tissue from the active agent during delivery.
Epocal is implementing an entire blood diagnostic 'laboratory on a chip' in FlexCard™ technology, with some elements are fabricated in media with micrometer or nanometer scale flow channels or pores.
The company develops unique molecular delivery systems. Its spherical micrometer sizes polymer particles act like micro sponges and absorb molecules while the sub-micrometer sized Hollow silica shells have an internal void space and act much like a standard container.
Worldwide company discovers, manufactures and markets molecular biology products and provides custom & OEM manufacturing service for pharma, diagnostic & life science research markets.
Manufactures Medusa®, a self-assembled poly-aminoacid nanoparticles system that is a versatile protein carrier for the development of novel and second-generation long-acting native protein drugs.
Fluxion develops cellular analysis tools in the pharmaceutical, biotech and research industries. The company has developed a proprietary microfluidic platform which enables precise cellular manipulation, rapid low-volume compound addition, environmental control and software-based data acquisition.
Develops a family of nanocomposite materials designed to increase mechanical performance in medical applications.